We studied the extent and location of the mRNA expression of two suggested prostate cancer markers, TMPRSS2-ERG fusion gene and PCA3, in a systematic way in cross-sections of cancerous prostates containing both histologically benign and carcinoma areas. The gene discussed is PCA3; the disease is carcinoma.